Literature DB >> 7017401

Clinical trial in Duchenne dystrophy. I. The design of the protocol.

M H Brooke, R C Griggs, J R Mendell, G M Fenichel, J B Shumate, R J Pellegrino.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7017401     DOI： 10.1002/mus.880040304

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN： 0148-639X            Impact factor:   3.217


× No keyword cloud information.
  107 in total

1.  Pentoxifylline as a rescue treatment for DMD: a randomized double-blind clinical trial.

Authors:  D M Escolar; A Zimmerman; T Bertorini; P R Clemens; A M Connolly; L Mesa; K Gorni; A Kornberg; H Kolski; N Kuntz; Y Nevo; C Tesi-Rocha; K Nagaraju; S Rayavarapu; L P Hache; J E Mayhew; J Florence; F Hu; A Arrieta; E Henricson; R T Leshner; J K Mah
Journal:  Neurology       Date:  2012-03-07       Impact factor: 9.910

2.  Myopathy in a 20-year-old female patient with D4ST-1 deficient Ehlers-Danlos syndrome due to a homozygous CHST14 mutation.

Authors:  N C Voermans; M Kempers; M Lammens; N van Alfen; M C Janssen; C Bönnemann; B G van Engelen; B C Hamel
Journal:  Am J Med Genet A       Date:  2012-03-09       Impact factor: 2.802

3.  Pulmonary and upper limbs function in children with early stage Duchenne muscular dystrophy compared to their healthy peers.

Authors:  Numan Bulut; Güllü Aydın; İpek Alemdaroğlu-Gürbüz; Ayşe Karaduman; Öznur Yılmaz
Journal:  Braz J Phys Ther       Date:  2020-06-05       Impact factor: 3.377

4.  Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD).

Authors:  F Fatehi; A A Okhovat; Y Nilipour; M Mroczek; V Straub; A Töpf; A Palibrk; S Peric; V Rakocevic Stojanovic; H Najmabadi; S Nafissi
Journal:  Eur J Neurol       Date:  2020-07-24       Impact factor: 6.089

5.  Patterns of decline in upper limb function of boys and men with DMD: an international survey.

Authors:  Mariska M H P Janssen; Arjen Bergsma; Alexander C H Geurts; Imelda J M de Groot
Journal:  J Neurol       Date:  2014-04-01       Impact factor: 4.849

6.  Muscle fat-fraction and mapping in Duchenne muscular dystrophy: evaluation of disease distribution and correlation with clinical assessments. Preliminary experience.

Authors:  Michele Gaeta; Sonia Messina; Achille Mileto; Gian Luca Vita; Giorgio Ascenti; Sergio Vinci; Antonio Bottari; Giuseppe Vita; Nicola Settineri; Daniele Bruschetta; Sergio Racchiusa; Fabio Minutoli
Journal:  Skeletal Radiol       Date:  2011-11-10       Impact factor: 2.199

7.  A modified Hammersmith functional motor scale for use in multi-center research on spinal muscular atrophy.

Authors:  Kristin J Krosschell; Jo Anne Maczulski; Thomas O Crawford; Charles Scott; Kathryn J Swoboda
Journal:  Neuromuscul Disord       Date:  2006-06-05       Impact factor: 4.296

8.  Feasibility and effectiveness of a novel dynamic arm support in persons with spinal muscular atrophy and duchenne muscular dystrophy.

Authors:  Mariska M H P Janssen; Jolinda Horstik; Paulien Klap; Imelda J M de Groot
Journal:  J Neuroeng Rehabil       Date:  2021-05-21       Impact factor: 4.262

9.  Upper and Lower Extremities in Duchenne Muscular Dystrophy Evaluated with Quantitative MRI and Proton MR Spectroscopy in a Multicenter Cohort.

Authors:  Sean C Forbes; Harneet Arora; Rebecca J Willcocks; William T Triplett; William D Rooney; Alison M Barnard; Umar Alabasi; Dah-Jyuu Wang; Donovan J Lott; Claudia R Senesac; Ann T Harrington; Erika L Finanger; Gihan I Tennekoon; John Brandsema; Michael J Daniels; H Lee Sweeney; Glenn A Walter; Krista Vandenborne
Journal:  Radiology       Date:  2020-04-14       Impact factor: 11.105

10.  A multinational study on motor function in early-onset FSHD.

Authors:  Jean K Mah; Jia Feng; Marni B Jacobs; Tina Duong; Kate Carroll; Katy de Valle; Cara L Carty; Lauren P Morgenroth; Michela Guglieri; Monique M Ryan; Paula R Clemens; Mathula Thangarajh; Richard Webster; Edward Smith; Anne M Connolly; Craig M McDonald; Peter Karachunski; Mar Tulinius; Amy Harper; Avital Cnaan; Yi-Wen Chen
Journal:  Neurology       Date:  2018-03-14       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.